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Systematic toxicity testing, using conventional toxicology methodologies, of single chemicals and
chemical mixtures is highly impractical because of the immense numbers of chemicals and
chemical mixtures involved and the limited scientific resources. Therefore, the development of
unconventional, efficient, and predictive toxicology methods is imperative. Using carcinogenicity
as an end point, we present approaches for developing predictive tools for toxicologic evaluation
of chemicals and chemical mixtures relevant to environmental contamination. Central to the
approaches presented is the integration of physiologically based pharmacokinetic/
pharmacodynamic (PBPK/PD) and quantitative structure-activity relationship (QSAR) modeling with
focused mechanistically based experimental toxicology. In this development, molecular and
cellular biomarkers critical to the carcinogenesis process are evaluated quantitatively between
different chemicals and/or chemical mixtures. Examples presented include the integration of
PBPK/PD and QSAR modeling with a time-course medium-term liver foci assay, molecular
biology and cell proliferation studies, Fourier transform infrared spectroscopic analyses of DNA
changes, and cancer modeling to assess and attempt to predict the carcinogenicity of the series
of 12 chlorobenzene isomers. Also presented is an ongoing effort to develop and apply a similar
approach to chemical mixtures using in vitro cell culture (Syrian hamster embryo cell
transformation assay and human keratinocytes) methodologies and in vivo studies. The promise
and pitfalls of these developments are elaborated. When successfully applied, these approaches
may greatly reduce animal usage, personnel, resources, and time required to evaluate the
carcinogenicity of chemicals and chemical mixtures. Environ Health Perspect 106(Suppl 6):
1385-1393 (1998). http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-6/1385-1393yang/abstracthtml
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This paper is a presentation ofthe ongoing
development ofconcepts and approaches
toward predictive and alternative toxicology,
particularly for chemical mixtures, from
our laboratories, with collaboration from
U.S. and European scientific colleagues.
As a starting point, one asks why such a
development is necessary. To answer this
question adequately, certain reality checks
must be emphasized:
There Is No SuchThing
as aSingleChemicalExposure
This issue has been discussed in detail else-
where (1-3). Briefly, a single chemical
often ends up with many metabolites in
the body. Furthermore, considering the
multiple chemicals to which we are com-
monly exposed in foods, drinks, medicines,
cosmetics, and indoor and outdoor pollu-
tants and the fact that even our own body
is a chemical mixture, there is really no
such thing as a single chemical exposure in
anyone's life.
ConventionalToxicologyStudies
CannotKeep PacewithSingle
Chemicals, LetAloneChemical
Mixares
The National Cancer Institute's Carcino-
genesis Bioassay Program was established
in 1962 (4). This bioassay program was
later transferred to the U.S. National
Toxicology Program upon its establish-
ment in 1978. In the bioassay program's
combined 36 years ofoperation, approxi-
mately 500 chemicals have been studied
for carcinogenicity and other chronic toxi-
cities (5). These studies and the related
range-finding and dose-setting studies are
extremely expensive, they require large
numbers of animals, and the study dura-
tion is long (6). Even though these studies
are the gold standards, considering the
approximately 70,000 to 600,000 chemi-
cals in commerce (7-9), the number of
chemicals for which we currently have ade-
quate toxicology information for risk assess-
ment is minuscule. At the present mode
and rate ofstudy of these chemicals, it is
doubtful that our society will ever have a
thorough toxicologic evaluation on the
majority ofthe chemicals that are used now
or may be used in the future. Further con-
sideration of the issue of health effects of
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chemical mixture exposures (i.e., real-world
issues), it is impossible to deal with the
problems of combination toxicology of
chemical mixtures byadopting the approach
ofsystematic conventional toxicology and
carcinogenicity testing (1,10).
Predictive andAltemativeToxicology
MustBeDeveloped
During our approximately 15 years of
active research in the toxicology ofchemical
mixtures, we have become resigned to the
fact that the conventional animal toxicology
testing methods will not work for chemical
mixtures, particularly in the evaluation of
carcinogenicity (2,3,6). We believe that to
deal with chemical mixture issues effectively
we must fully utilize and integrate compu-
tational technology, mathematical and sta-
tistical modeling, mechanistically based
short-term toxicology studies, and cellular
and molecular biology methodologies.
Furthermore, an efficient experimental
approach or system for chemical mixtures
must at least meet the following critical
requirements: It must be relatively simple,
short-term, and inexpensive; be based on
the best science; incorporate mechanisms of
toxicity; have broad applicability; and have
predictive capability.
TheInaeasingApplication
ofComputerTecnology
inToxicologyIs Inevitle
Widespread application of computers in
risk assessment, particularly the use of
linearized multistage and other models for
cancer risk assessment, has been a reality for
more than two decades. Since the late
1980s, the advancement ofphysiologically
based pharmacokinetic (PBPK) modeling
and the integration of PBPK/pharmaco-
dynamic (PD) modeling into the risk
assessment process further enhanced the
utilization ofcomputer technology. Thus,
computer application in toxicology is
already a fact. Looking into the future, it
becomes obvious that some type ofpredic-
tive approach must be developed to handle
the huge number ofsingle chemicals in
commerce and the nearly infinite number
ofchemical mixtures in the environment. It
is inevitable that computer technology will
be heavily involved in any development of
predictive toxicology.
Prediction of health effects usually
involves some type of mathematical mod-
eling, which may range from the classical
compartmental pharmacokinetic model-
ing to the currently advancing PBPK/PD,
biologically based dose response (BBDR),
and/or quantitative structure-activity
relationship (QSAR) modeling. Some suc-
cesses, including those from our studies,
in prediction ofpharmacokinetic fate and
toxicity of simple chemical mixtures are
already evident in the literature (11-22).
The toxicologic end points ofprediction,
for instance, include an interaction
threshold (18,19) and acute lethality due
to hepatic injuries (20).
For more complex mixtures the
integration of PBPK/PD, BBDR, QSAR
modeling, and lumping analysis (a model-
ing tool developed in the petroleum indus-
try) may allow the development of a
predictive tool for the health effects (23).
In the 1960s the application of lumping
analysis rendered it possible to predict gaso-
line production based on a few lumps (i.e.,
similar groups ofchemicals based on car-
bon numbers or boiling points) rather than
the thousands ofcomponent chemicals of
the petroleum (24,25). Thus, even though
relatively little is known about the complex
mixture ofpetroleum, a predictive tool was
developed and applied from modeling. Ifa
relatively crude lumping analysis was able
to predict some aspects ofcatalytic cracking
ofpetroleum 30 years ago, why can't we
attempt to predict health effects from
chemical mixtures through a much more
sophisticated modeling technique such as
structure-oriented lumping (26,27)?
Accordingly, our laboratory, in conjunction
with scientists from other institutions, is
activelypursuing this areaofresearch (28).
Long-Term, Low-LeviExposuresAre
BdlowtheSensitivityofPresent-Day
Methods ofExperimentalToxicology
Conventional toxicology methods are
mainly observational and descriptive. As an
example, in carcinogenesis the animals,
usually rodents, are dosed with the chemi-
cal ofinterest for 2 years, the surviving ani-
mals are sacriflced, and the tissues are
examined histopathologically for the pres-
ence of tumors. Because the number of
animals per group is limited, usually fairly
high dose levels must be used to elicit
tumorigenic responses. In cancer risk
assessment these high-dose experimental
results are extrapolated to the very low dose
(i.e., environmentally realistic) regions
where such conventional experimental pro-
tocols would not be able to detect any car-
cinogenic responses. Even with the newly
proposed point ofdeparture approach for
cancer risk assessment (29), the lower 95%
confidence limit on a dose associated with
5 or 10% extra risk (LED05 or LEDIO,
respectively) region isstill noteasilyattainable
with conventional protocols. Moreover,
these dose levels (i.e., effective dose, ED05
or EDIo) are still orders of magnitude
higher than the estimated environmental
exposure levels.
Recent advances in molecular biology
techniques offer unique opportunities for
the development ofmore efficient and sen-
sitive methods for toxicology. For instance,
techniques such as polymerase chain reac-
tion or reverse transcriptase polymerase
chain reaction, coupled with mechanistic
studies ofthe cancer process in cell culture
systems, may detect early or late genotypic
changes related to carcinogenesis at dose
levels much below the limits ofdetection
ofmore conventional toxicology methods.
As we propose here, the integration ofthis
type ofmechanistic data with PBPK/PD,
BBDR, and/or QSAR modeling may for-
mulate an efficient and predictive approach
for carcinogenic potentials of chemicals
and chemical mixtures.
Because this is a review paper, many
experimental details are not provided.
Readers are referred to the papers cited for
additional information. The following
discussion will follow the chronological
order ofdevelopment ofthese approaches
in our laboratories.
Experimental Approaches
This portion of the paper follows the
evolution of our thinking in the last few
years on how to develop predictive
approaches for single chemicals and chemi-
cal mixtures. To focus our presentation we
chose to limit the discussion to carcinogen-
esis only. Initially, we concentrated our
effort on a medium-term (i.e., 8 weeks) in
vivo experimental approach and its integra-
tion with PBPK/PD modeling. Although
we made progress on this front and
obtained interesting findings, it was soon
obvious that even this shorter term, more
efficient in vivo system was too resource
intensive to be routinely used for chemical
mixture work. Therefore, still more effi-
cient systems must be developed. We
investigated in vitro systems with our spe-
cific criteria (i.e., relatively simple, short-
term, and inexpensive; based on the best
science; understanding mechanisms oftox-
icity; broad applicability; and predictive
capability) in mind. We found that cell
culture systems offer unique opportunities,
particularly in mechanistic and time-course
studies related to carcinogenesis. Thus, as a
further development, in vitro mechanistic
studies using cell culture systems and their
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integration with pharmacodynamic
modeling became a major emphasis in our
laboratories. Our present thinking is that
cell culture systems and in vivo animal
studies may work in concert to bring about
much-needed mechanistic and pharmaco-
kinetic information for PBPK/PD model-
ing. When quantitative information on the
selected molecular and cellular end points
is available on chemicals with structural
correlation, QSAR modeling may then be
applied to assess their relationship with car-
cinogenic potentials. In doing so, the posi-
tive QSAR relationship between certain
end points of a series of chemicals with
their respective carcinogenic potentials may
be used to develop a predictive approach
for other untested chemicals with
structural similarities.
TheMedium-Term LiverFoci Bioassay
To simplify the detection ofcarcinogenicity
of chemicals and chemical mixtures, Ito
and colleagues developed the medium-term
liver foci bioassay (30,31). The details of
experimental protocol ofthis bioassay may
be found in Ito et al. (30,31); the bioassay
is discussed briefly below.
The medium-term liver foci bioassay
(30,31) utilizes the placental form ofglu-
tathione S-transferase (GST-P) as a marker
for rat hepatic preneoplastic and neoplastic
lesions (32,33). The medium-term hepato-
carcinogenesis bioassay ofIto et al. (30,31),
an 8-week experiment, utilizes F344 rats
that are given a single dose of diethylni-
trosamine (DEN) to initiate carcinogenesis.
After a 2-week period the rats are given
repeated exposure to a test compound for a
dosing period of 6 weeks. At the end of
week 3, rats are subjected to partial hepatec-
tomy to maximize opportunities ofpromo-
tion via a high rate ofcell proliferation. All
rats are sacrificed at the end ofweek 8 for
evaluation ofdevelopment ofpreneoplastic
hepatocellular nodules by staining for
expression of GST-P (30,31). Extensive
testing has demonstrated that the induction
ofGST-P-positive foci in the medium-term
bioassay for liver carcinogens correlates well
with the incidence ofhepatocellular carci-
nomas in parallel long-term assays (30,31).
Two hundred seventy-seven chemicals have
been tested in Ito et al.'s (34) medium-
term liver foci bioassay; it has correctly
identified 97% ofgenotoxic hepatocarcino-
gens and 84% ofnongenotoxic hepatocar-
cinogens (34). Thus, for rapid screening of
large numbers ofchemicals and for reduc-
tion in the required number ofanimals, this
assay is ofgreat advantage.
AModifiedTlme-Course
Medium-TermLiverFoci Bioassay
In the original protocol of Ito et al.'s
(30,31) medium-term liver foci bioassay,
the animals undergo terminal sacrifice at
the end of the 8-week experimental period
and the data are for only one time point.
To obtain sufficient data for constructing a
viable PBPK/PD model ("Integration ofIn
Vivo Studies and PBPK/PD Modeling"),
time-course events must be studied.
Therefore, we modified the original Ito et
al. (30,31) protocol into time-course
studies based on anticipated cell prolifera-
tion rates during this 8-week experimental
period (Figure 1). With this modified pro-
tocol we obtained pharmacokinetic data,
cell proliferation rates, selected molecular
and biochemical information (i.e., c-jun, c-
fos, CYP1A2, reduced glutathione (GSH):
oxidized glutahione (GSSG) ratios, por-
phyrin levels) as well as morphometric data
on foci at different stages ofthe foci devel-
opment following treatment of several
individual chlorobenzene isomers. Detailed
descriptions ofmethodologies involved in
the measurement of these parameters are
discussed in Thomas et al. (35,36) and
Thomas (37).
Integation ofin VivoStudies
andPBPK/PD Modeling
The PBPK/PD modeling of Ito et al.'s
(30,31) medium-term liver foci bioassay
presented some unique challenges. Whereas
the foundation of this modeling approach
was laid by using pentachlorobenzene (37)
as a model system, the principle is applica-
ble for other chemicals or chemical mix-
tures. The evolution ofthe approach for a
0
Weeks
4 6
PBPK/PD model for tumorigenesis in our
laboratories followed roughly three stages.
The first stage was the most ambitious
stage, in which we formulated a model as
shown in Figure 2. Because cell-cycle
kinetics was incorporated into this model,
our initial effort was devoted to a biologi-
cally based mathematical model of the
effects ofpartial hepatectomy on cell cycle
kinetics (38) and a comparison ofquanti-
tative immunohistochemical markers for
cell-cycle specific changes in F344 rats
(39). However, it was soon apparent that
there were two pitfalls. First, whereas the
proliferating cell nuclear antigen staining
appeared to work well for the liver cells
undergoing rapid proliferation such as after
two-thirds partial hepatectomy (39), quan-
titative morphometric analysis would be
prohibitively resource-intensive for liver at
resting state, which has a low rate ofcell
turnover. Second, although a biologically
motivated model depicting cell-cycle kinetics
a)
Co 4- =
c_ 0
Co 0.4 Q
=-
8
Figure 1. Experimental protocol for the modified time-
course of Ito's medium-term liver foci assay (30,31).
Abbreviations: PH, partial hepatectomy; LI, labeling
index. Each arrow under the time axis depicts the fol-
lowing experimental procedures: 1) sacrifice five
rats/group/time point following a 3- to 5-day bromod-
exyuridine exposure; 2) liver tissue for Ll measurement;
3) liver tissue for molecular biology studies; 4) tissues
for chemical analyses; 5) liver tissue for oxidative
stress studies; and 6) histopathology and morphometric
analyses on liver.
Figure 2. Diagram of a pharmacodynamic model for
the liver foci development for selected chlorobenzene
isomers. Biologic processes governing cell replication
and preneoplastic lesion have been expressed in terms
of fundamental cell cycle kinetics within the frame-
work of a multistage model for cancer events. The cel-
lular stages are labeled G1, S, G2, and M. Krep(DNA),
kinj(DNA), kinit, kprolif are rate constants for DNA
repair, DNA injury, cell initiation, and cell proliferation,
respectively. Kdie 1 through 4 are rate constants for
cell death for the respective compartments.
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was constructed and computer simula-
tions were consistent with available litera-
ture data (38), the data requirements for
applying such a model to the specific
chemicals and bioassay systems that we
were studying were beyond the reach of
our available resources and personnel.
Thus, we were overly ambitious in our
initial modeling attempt.
In the next stage we simplified the
model greatly. As shown in Figure 3, this
model depicts (from the top to the
bottom) that the normal cells have a
growth function (PN) that is related to the
total number of cells, their proliferation
rate, and time. These cells may die at a
death rate (kdiel) or may be injured (DNA
damage) by chemicals at the rate ofkinj.
The cellular repair processes may fix the
damage at the rate ofkrep. The injured cell
may go on to become initiated cells (foci)
at the rate ofkinit or go on to die at the
death rate ofkdie2. The initiated cells have
their growth function (PI) and death rate
(kdie3) as well. This model (Figure 3) was
a prototype and we kept it as simple as pos-
sible. Using this model, we attempted to
simulate the data published by Tatematsu
et al. (40) on time-course studies of liver
foci development and the liver growth fol-
lowing DEN initiation, phenobarbital pro-
motion, and partial hepatectomy. The
results are shown in Figures 4 and 5. The
model simulations in Figures 4 and 5 (solid
PBPK model
lines) are consistent with the experimental
data on both the foci development and the
liver growth. Although not shown here, the
DEN/control (vehicle instead ofphenobar-
bital) showed similar consistent results
between computer simulation and experi-
mental data from Tatematsu et al. (40).
Our subsequent modeling effort (stage
3) was directed toward the linking of a
PBPK model with the first two cellular
states of the two-stage cancer model (the
Moolgavkar-Venzon-Knudson model). Part
one of the modeling effort involved the
PBPK simulation ofsingle- and multiple-
gavage dose exposures (37)-a reflection of
the experimental procedures. Part two took
into consideration the physiologic changes
resulting from two-thirds partial hepatec-
tomy (37)-a drastic physiologic state. Part
three included linking a deterministic model
with a stochastic model and the pharmaco-
dynamic processes involved in the forma-
tion of foci (37), the initiated cells in the
two-stage carcinogenesis model. To date, all
these modeling activities were based on
using pentachlorobenzene as a model chem-
ical in the modified time-course medium-
term liver foci bioassay system. However,
the principles derived from this effort may
easily be applicable to chemical mixtures.
Our present and future modeling
direction aims at going beyond the initiated
cell stage-i.e., to look at the processes
involved in the later events ofthe multistage
carcinogenesis process. Relevant discussion
follows in "The Integration ofMechanistic
Information from in Vitro and in Vivo
Studiesand Pharmacodynamic Modeling."
StudiesofMechanismsof
Carcinogenesis UsingCdlCultures
followingTreatmentofChemicals
andlorChemicalMixtures
Cell culture systems, because of their
simplicity and low cost, make it possible to
determine the oncogenic potential and
mechanisms oftransformation ofa variety
ofchemicals and chemical mixtures at the
cellular level. Syrian hamster embyro (SHE)
cells have the advantage that the carcino-
genic potential ofmany chemicals has been
evaluated using morphologic transforma-
tion as an index. This has largely been
through the effort of scientists at The
Procter & Gamble Company (41,42).
Epidermal keratinocytes are one of the
most well-characterized cell culture systems
forstudying transformation.
For both SHE cells and human
keratinocytes, cytotoxicity and altered cellu-
lar growth characteristics and induced
malignant transformation (i.e., tumori-
genicity) are end points for the evaluation
of chemical mixtures of interest. In addi-
tion, in keratinocytes these studies may be
extended to link observed phenotypic
changes with alterations in expression of
defined cell cycle regulators and growth fac-
tors. These biologic experiments should be
carried out in an iterative manner with the
development ofa biologically based model.
The concept ofmodel-directed experimen-
tation should be followed to save resources
byavoiding unnecessary experimentation.
The overall idea ofstudying the carcin-
ogenesis process using human keratinocytes
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Figure 3. A simplified PBPK/PD model for preneoplastic
foci development in the rat liver. See text and Figure 2
for explanation ofvarious functions and rate constants.
Figure 4. PBPK/PD model simulation of total liver cell
volume under the experimental conditions of Ito's liver
foci assay using DEN as an initiator and phenobarbital
as a promoter. PH was performed on week 3; however,
it is shown here at about 168 hr because the simula-
tion (solid line) started at 1 week before PH when phe-
nobarbital treatment began. Data from Tatematsu et
al. (40).
Figure 5. PBPK/PD model simulation of the develop-
ment of liver foci (foci area) under the experimental
conditions of Ito's liver foci assay using DEN as an ini-
tiator and phenobarbital as a promoter. PH was per-
formed on week 3; however, it is shown here at about
168 hr because the simulation (solid line) started at 1
week before PH when phenobarbital treatment began.
Data from Tatematsu et al. (40).
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Figure 6. A schematic review of the literature showing phenotypic and genotypic alti
keratinocytes during the multistage process ofcarcinogenesis. GF, growth factor.
is summarized in Figure 6. There are many
phenotypic and genotypic changes accom-
panying the transformation of human
keratinocytes; some are early events and
others are late events. To cover these
changes, commercially available primary
human keratinocytes may be used to study
the early events (43). A number ofimmor-
tal keratinocyte cell lines such as HaCat
(44), RHEK-1 (45), and NM-1 (46) can
be used to study the later events. Selected
pertinent biomarkers such as transforming
growth factor (TGF)-a, TGF-3, c-myc,
c-ras, and p53 may be studied and quanti-
tative information obtained. Such quanti-
tative information may be utilized to
calibrate and verify BBDR models.
Integraton ofMechanistic
Information ffrom in Vtro
and in VivoStudies and
Pharmacodynamic Modeling
We summarize ourapproach on the integra-
tion ofmechanistic information and model-
ing for the assessment of carcinogenic
potential for chemicals in the algorithm in
Figure 7.
We believe that because cancer is a
cellular process, the carcinogenic potential
ofchemicals can be identified through the
studies ofselected key molecular/cellular
markers of the cancer processes; also,
QSAR and pharmacodynamic modeling of
these key biomarkers for cellular process
can be effectively utilized to develop a
predictive tool for evaluating carcinogenic
potential within certain classes ofchemicals.
We listed multiple chemicals for chemi-
cal mixtures, but this general approach
(Figure 7) is applicable for s
as well. The short-term alt
may be represented by the
'
formation assay and the n
course medium-term li
(Figure 1); other such test
The molecular or cellular b
a number of processes le
cancer (including loss ofg
failure to commit apoptosi
repair) may be specificall)
compound or a class ofcon
time-course studies, critical
(e.g., cellular birth, death,
rates for primary and imm(
of changes of growth fa
expression of oncogene at
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structing the cancer model(s
data on the selected molecu
markers for the cancer proce
in QSAR modeling for a clk
or chemicals with structur
Such integration of QSAR,
ing, and cancer modelin
modeling) will then provide
for developing predictive t
risk assessment.
Integraton ofPBPK/PD
ModIelingfortheDevelop
ofPredictiveCapability
For the last few years, we 1
great deal of effort towarc
predictive toxicology appr
homolog series of 12 chloro
will use chlorobenzenes a,
the same general princip
applicable to other classes of
Malignant The chlorobenzenes are a small group
keratinocyte. of congeneric chemicals. There are 12
congeners in total-from mono- to hexa-
chlorobenzene. Most of these are solid at
ambient temperature and pressure, except 4. for mono- and some dichlorobenzenes.
Their water solubility is generally low to
Malignant extremely low, and their hydrophobicity
tumors ranges from intermediate to fairly high.
f ? The log octanol/water partition coeffi-
Benign cient for monochlorobenzene is 2.89, tu |ongc whereas for hexachlorobenzene it is 5.73
i ra incyte (47). In a QSAR model, a correlation is
developed between one or more quantita-
tive structural, physicochemical, and/or S_ biologic descriptors and a toxicologic end
Paptiloma point (48). The toxicologic end point can
formaton either be quantitative (e.g., an effect level
such as the median lethal concentration) erations in human or qualitative (e.g., mutagenic or nonmu-
tagenic). Hansch et al. (49) provide an
interesting overview of the use of QSAR
,ingle chemicals in toxicology.
ternative assays Our plan is to build and verify QSAR
SHE cell trans- models based on our ongoing studies of
nodified time- molecular and cellular biomarkers of pre-
ver foci assay neoplastic foci formation from exposures
:s are available. to hexa-, penta-, 1,2,4,5-tetra-, and 1,4-
iomarkers from dichlorobenzenes; to use these verified
ading toward QSAR models to predict each of the toxi-
,rowth control, cologic responses and PBPK modeling
s, loss of DNA parameters studied to date for the remain-
f targeted by a ing eight chlorobenzene isomers (1,2,3,4-
npounds. From tetra-, 1,2,3,5-tetra-, 1,2,3,-tri-, 1,2,4,-tri-,
rate constants 1,3,5-tri-, 1,2-di-, 1,3-di-, and mono-
and mutation chlorobenzenes); and to verify the QSAR
Drtal cells, rates model predictions by conducting molecu-
ctors, and/or lar biology/biochemical experiments and
nd tumor-sup- PBPK/PD modeling studies on selected
erated for con- chlorobenzene isomers using in vitro and
s). Quantitative in vivo methods. To achieve that we will
lar/cellular bio- proceed as follows:
ess may be used The array of toxicologic data on the
ass ofchemicals first four selected chlorobenzenes will be
ral similarities. studied using pattern recognition methods
PBPK model- (50,51) to determine which data correlate
g (i.e., PBPD with the carcinogenic nature of the com-
5 us with a tool pounds. The methods that will be used are
toxicology and principal component analysis, linear dis-
criminant analysis, cluster analysis, and
soft independent modeling ofclass analogy
and QSAR (50,51). All of these methods can be used
?ment to study which biologic descriptors (or
combination ofdescriptors) are correlated
have devoted a with or even responsible for the carcino-
A developing a genic nature of the active chlorobenzenes.
oach using the In the next step the toxicologic end points
obenzenes. We that are perceived important for the
s a case study; understanding of the carcinogenicity of
dles should be these compounds will be studied with
chemicals. quantitative methods.
Environmental Health Perspectives * Vol 106, Supplement 6 * December 1998
DNA
'TGF-I
T. r r
Primary ;w ioWke( Angii
keratinocyts An.ch
p53lossorfputaion ia!
OFoweression d ..on
Increased grothra,te. rqsitance
Chronosoiidiwase.
*Loseoseneseknie Ones
1389YANG ETAL.
Chemicals 1, 2,3... (singly; in combination)
Signal Cell cycle Cell Stimulatory/ DNA
transduction kinetics proliferation inhibatory da ge
Ohr
1 ~~~~check points
Chemicals 1, 2, 3...
(singly; in
combination)
>2....* Stop
< - QSAR
No >-~ Stop
Figure 7. An algorithm for our approach to predictive and alternative toxicology for assessing carcinogenic
potentials of chemicals or chemical mixtures.
indices derived thereof. These methods
include the highest occupied molecular
orbital and the lowest unoccupied molecu-
lar orbital energies and densities, polariz-
abilities, (super) delocalizabilities (55-57),
or transition-state-based reactivities
(58,59), and connectivity or other graph-
theoretical indices (60-64) that will be
calculatedwith the appropriate programs.
To date, the TRs measured in our
ongoing project on hexa-, penta-, 1,2,4,5-
tetra- and 1,4-dichlorobenzenes include
GST-P-positive foci (numbers and area);
alteration of c-jun and c-fos expression
(thus AP-1 related gene expression of
GST-P); changes in CYP1A2 expression
(thus Ah-receptor related activity); liver
porphyrin levels (possible involvement of
oxidative stress); alterations in the
GSH:GSSG ratio; and induction of DNA
damage (via Fourier transform infrared
analyses). Furthermore, time-course
changes were also obtained for liver cell
proliferation rates under the influence of
DEN, chlorobenzene treatment, and par-
tial hepatectomy in the modified time-
course medium-term liver foci bioassay
(Figure 1). All these TRs are either quanti-
tative or semiquantitative parameters;
thus, they are amenable to QSAR analysis.
Of course, judgment on the potency and
importance of these TRs must be made
with respect to the toxicologic end point,
in this case the foci formation.
For QSAR correlation and prediction of
PBPK modeling parameters on the 12 iso-
mers ofchlorobenzenes, we also intended to
apply the following general QSAR model
for all relevant PBPK parameters:
QSAR correlation and prediction of
toxicologic responses on a number ofmolec-
ular or cellular biomarkers for carcinogenic
potentials ofthe 12 isomers ofchloroben-
zenes will be carried out in line with the
classical Hansch multiple linear regression
(MLR) analysis approach (52-54). The
correlation developed will be similar to the
following description, with the understand-
ing that actual relationships will be calcu-
lated using partial least square (PLS)
regression analysis (a projection multivariate
technique) rather than MLR.
log - = act +bp+cy +da+
TR
This equation, in a general sense, expresses
that the toxicologic response (TR) mea-
sured is a function of a number of factors
(aa, bp, cy, d, ...). Here, a, b, c, d, ... are
QSAR model coefficients that may be
derived after the model verification from
data obtained with the four isomers (i.e.,
hexa-, penta-, 1,2,4,5-tetra- and 1,4-
dichlorobenzenes) that we are currently
studying, whereas a, /3, y, 8, ... are the spe-
cific numeric derivations ofphysicochemi-
cal parameters retrieved from literature
and/or comprehensive databases. Examples
ofa, 3, y, 3, ... are log K,, (hydrophobic-
ity), melting point, vapor pressure, or
Swain-Scott parameters. The latter are elec-
tronic parameters generated by theoretical
chemical methods-quantum chemical cal-
culations and several reactivity/interaction
log - = act +b/3 +cy + da + PK
where PKrepresents PBPK model parame-
ters measured or estimated.
The PKs measured or estimated to
date in our ongoing project on hexa-,
penta-, 1,2,4,5-tetra- and 1,4-dichloro-
benzenes include tissue partition coeffi-
cients for liver, fat, muscle (representing
a slowly perfused tissue group), and
kidney (representing a rapidly perfused
tissue group) and in vivo metabolic rate
constants (i.e., Km and Vmax). The priority
ofselecting PKs for QSAR modeling will
be based on sensitivity analyses in PBPK
modeling as to their respective influences
on computer simulations; the greater the
influence, the higher the priority.
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The work ofde Jongh and co-workers
(65) showed that for a large set ofdiverse
chemicals, in both rats and humans, the tis-
sue:blood partition coefficients could be
described by a general function of the
compound's log Kowofthe following form:
ft,t +f4X(K0W) tw b +fz^ (Kow)
where Pt,b is the tissue to blood partition
coefficient, fW,t is the fraction ofwater in
the tissue,fl,t is the fraction oflipid in the
tissue, ft,b is the fraction ofwater in the
blood, flb is the fraction of lipid in the
blood, a and b are exponents, and Cis an
adjustment factor to provide for the effect
ofprotein binding. This methodology will
be used for QSAR modeling oftissue parti-
tion coefficients. For metabolic rate con-
stants, the Hansch-like approach using PLS
as described earlier.
Conclusion
In this paper we described the approaches
for the possible development ofa predic-
tive tool for the carcinogenic potential of
chemicals and chemical mixtures. For
illustrative purposes we used single chemi-
cals (i.e., chlorobenzenes) to develop the
concept and approach for predicting
carcinogenic potentials ofdifferent isomers of
chlorobenzenes. Toxicologic interactions may
be at the levels ofpharmacokinetics and/or
pharmacodynamics. Those toxicologic
interactions that are relevant to the end
point (in this case carcinogenicity) may be
linked for different chemicals in a chemi-
cal mixture via PBPK/PD modeling.
QSAR modeling may be used to extrapo-
late to other chemicals that are struc-
turally similar to the components of a
chemical mixture under study. In this
integrated manner we may develop pre-
dictive capabilities for the toxicology of
chemical mixtures.
How do we approach the issue of risk
assessment once such modeling and the
generation ofquantitative information are
realized? The linchpin of a realistic risk
assessment is an accurate estimate oftarget
tissue dosimetry from which a virtually
safe or safe exposure dose may be calcu-
lated. PBPK/PD or BBDR models are
powerful tools to define such target tissue
dosimetry. For chemical mixtures, three
scenarios can be considered. In the first
case where a simple chemical mixture with
known mechanism(s) of toxicologic inter-
action, PBPK/PD or BBDR modeling of
the toxicologic interaction can provide
estimates on an interaction threshold,
which may in turn be used as a benchmark
dose (e.g., LEDO0 or LED05 for a chemical
mixture) for risk assessment. In the second
case, a chemical mixture (most likely a
more complex one with structurally simi-
lar components such as a hydrocarbon
mixture) may provide quantitative changes
of many biomarkers for a toxicologic
process as well as defined toxicity for a spe-
cific end point. Although the mechanism(s)
of interaction may not be entirely clear,
PBPK/PD or BBDR modeling may be
utilized to estimate the target tissue
dosimetry of this chemical mixture as a
lump (i.e., a pseudosingle chemical) or as
an average chemical based on the average
characteristics of such a mixture. In the
third case a chemical mixture may have
completely different composition includ-
ing metals, aliphatics, and aromatics. The
principles and approaches stated previ-
ously may still apply as long as the like
components are lumped and quantitative
toxicologic information can be obtained
for each ofthe lumps.
The role of QSAR modeling in the
overall scheme is to provide interpolations
and extrapolations for estimated values for
TRs and PKs for those chemicals that are
not studied experimentally in a class of
chemicals (such as chlorobenzenes) or
chemical mixtures (such as hydrocarbons,
metals, etc.). These gaps may be filled
using QSAR based on structural differ-
ences and the related physicochemical
changes. In doing so we may carry out
PBPK/PD or BBDR modeling on these
chemicals or chemical mixtures on an a
priori basis.
Discussion in this paper consists ofpast
and ongoing studies as well as theoretical
deliberations. Much ofthe development is
still at an embryonic stage. We invite criti-
cisms and suggestions for further modifica-
tion and refinement of our approaches.
Through this type of process we will be
able to work toward the goal ofestablish-
ing a scientifically credible predictive and
alternative toxicology.
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